Zelnick Kaufman Beth 4/A
4/A · CorMedix Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4/AAmended
CorMedix Inc.CRMD
Zelnick Kaufman Beth
Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2024-12-12$8.77/sh−6,044$53,006→ 43,956 total
Footnotes (1)
- [F1]The reporting person has filed this amendment to restate the transaction reported in the Form 4 filed December 16, 2024 in order to correct the amount of Common Stock beneficially owned by the reporting person following the transaction and to remove a duplicative reference to the Restricted Stock Units reported in Table II. As reported in this amendment, the reporting person directly beneficially owns 43,956 shares of Common Stock following the reported transaction.